Please login to the form below

Not currently logged in
Email:
Password:

Orrin Pollard joins behavioural change agency Hamell

Theformer DDB Remedy chairman takes up an executive creative director role

Hamell Orrin PollardHamell has appointed Orrin Pollard as a partner and executive creative director in a role that will see him help launch new communications division Hamell Ignyte.

Pollard has been chairman at DDB remedy for 11 years, prior to which he was director and creative director at UK healthcare advertising agency Leavold Pollard Bardsley for eight years.

He said: “Many agencies talk about changing behaviour, but few actually have the evidence to back it up. “This is where Hamell Ignyte differs, because through our behavioural research division Hamell Spark, [and its] unique, validated methodology, we are able to get under the skin and into the minds of our target audiences to really discover their motivators and behavioural drivers.”

London-based agency Hamell was formed in 2008 and its new comms division will be driven by Pollard and Hamell's managing director Fiona Hammond and clinical director Alison Carr.

Commenting on Pollard's appointment, Hammond said: “We are absolutely thrilled that Orrin is joining us here at Hamell. He brings with him a wealth of experience, and his proven expertise will enable us to realise our vision of creating innovative communication solutions that facilitate real and lasting behavioural change.

“This is a step forward for Hamell and comes hot on the heels of some major new business wins in behavioural research. We are excited to be growing our full service agency and translating more of our in-depth behavioural insights into communications supported by memorable, engaging creative.”

10th November 2015

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics